Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jul 1;49(7):e338-e339.
doi: 10.1097/RLU.0000000000005264. Epub 2024 May 9.

Increased PSMA-Targeted 18 F-DCFPyL Uptake in Peripheral T-Cell Lymphoma

Affiliations
Case Reports

Increased PSMA-Targeted 18 F-DCFPyL Uptake in Peripheral T-Cell Lymphoma

Charles J Milrod et al. Clin Nucl Med. .

Abstract

Peripheral T-cell lymphomas are a heterogenous group of lymphomas with a high rate of extranodal disease. We present a case of increased 18 F-DCFPyL uptake in peripheral T-cell lymphoma of subcutaneous tissue and bone. Familiarity with the increased 18 F-DCFPyL uptake and extranodal presentation of peripheral T-cell lymphomas can avoid misinterpretation for metastatic disease.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest and sources of funding: A.M. reports consultancy for Bristol Myers Squibb. The rest of the authors have no conflicts of interest declared.

References

    1. Weisenburger DD, Savage KJ, Harris NL, et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the international peripheral T-cell lymphoma project. Blood . 2011;117:3402–3408.
    1. Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet . 2020;395:1208–1216.
    1. Wondergem M, van der Zant FM, Broos WAM, et al. Matched-pair comparison of 18 F-DCFPyL PET/CT and 18 F-PSMA-1007 PET/CT in 240 prostate cancer patients: interreader agreement and lesion detection rate of suspected lesions. J Nucl Med . 2021;62:1422–1429.
    1. Caputo SA, Jang A, Talbert J, et al. Prostate-specific membrane antigen PET positivity in a lung mass: diagnosis of diffuse large B-cell lymphoma. Clin Nucl Med . 2023;48:190–191.
    1. Dendl K, Merkel A, Kratochwil C, et al. Positive multifocal PSMA PET/CT in a patient with prostate cancer and follicular lymphoma. Clin Nucl Med . 2022;47:e47–e48.

Publication types

MeSH terms

Substances

LinkOut - more resources